Cancidas and Lopurin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cancidas (caspofungin acetate) and Lopurin (allopurinol). Common drug interactions include diarrhoea among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Cancidas and Lopurin. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.

What is Cancidas?

Cancidas has active ingredients of caspofungin acetate. eHealthMe is studying from 4,879 Cancidas users. Check the latest studies of Cancidas.

What is Lopurin?

Lopurin has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 190,798 Lopurin users. Check the latest studies of Lopurin.



On Aug, 04, 2026

88 people who take Cancidas and Lopurin together, and have interactions are studied.

Cancidas and Lopurin drug interactions.

What are the common drug interactions of Cancidas and Lopurin, by gender? *:

female:

  1. Diarrhoea
  2. Intestinal perforation (complete penetration of the wall of the intestine)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Venoocclusive disease (small veins in the liver are obstructed)
  5. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  6. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Septic shock (shock due to blood infection)
  10. Haematoma (collection of blood outside the blood vessels)

male:

  1. Pneumonia
  2. Acute respiratory failure
  3. Vertigo
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  6. Aspartate aminotransferase increased
  7. Back pain
  8. Cytomegalovirus infection
  9. Cytomegalovirus test positive
  10. Gamma-glutamyltransferase increased

What are the common drug interactions of Cancidas and Lopurin, by age (0-1 to 60+)? *:

0-1:

  1. Cardiac failure
  2. Prerenal failure
  3. Respiratory failure (inadequate gas exchange by the respiratory system)

2-9:

n/a

10-19:

  1. Dilatation intrahepatic duct acquired
  2. Hepatotoxicity (chemical-driven liver damage)
  3. Venoocclusive disease (small veins in the liver are obstructed)
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Alanine aminotransferase increased
  6. Arthralgia (joint pain)
  7. Back pain
  8. Blood alkaline phosphatase increased
  9. Blood bilirubin increased
  10. Congestive cardiomyopathy (weakening of heart muscle)

20-29:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Hyperbilirubinaemia (excess of bilirubin in the blood)
  3. Oesophagitis (inflammation of oesophagus)
  4. Infection
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Haemorrhagic diathesis (bleeding tendency)
  7. Hepatic lesion
  8. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  9. Liver abscess (pus in liver)
  10. Mucosal inflammation (infection of mucous membrane)

30-39:

  1. Acute promyelocytic leukaemia (cancer of the blood and bone marrow)
  2. Acute respiratory failure
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Aspergillosis (an infection caused by a fungus called aspergillus)
  6. Bacteria stool identified
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Cytomegalovirus infection
  10. Diastolic dysfunction

40-49:

  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  4. Diarrhoea
  5. Drug toxicity
  6. Fungal oesophagitis (fungal inflammation of the oesophagus)
  7. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  8. Hepatomegaly (abnormal enlargement of the liver)
  9. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  10. Hiv antibody positive

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Alanine aminotransferase increased
  3. Cardiac arrest
  4. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Gamma-glutamyltransferase increased
  8. Hepatorenal failure (decrease in kidney function in a person with a severe liver disorder)
  9. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  10. Mucosal inflammation (infection of mucous membrane)

60+:

  1. Pneumonia
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Renal impairment (severely reduced kidney function)
  4. Vertigo
  5. Diarrhoea
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Urinary tract infection
  10. Hypovolaemic shock (shock caused by severe blood or fluid loss)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 22 people, 25.00%
  2. Pain: 13 people, 14.77%
  3. High Blood Pressure: 10 people, 11.36%
  4. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 10 people, 11.36%
  5. Oedema (fluid collection in tissue): 8 people, 9.09%
  6. Multiple Myeloma (cancer of the plasma cells): 8 people, 9.09%
  7. Fever: 8 people, 9.09%
  8. Diabetes: 7 people, 7.95%
  9. Cardiac Failure: 7 people, 7.95%
  10. Insomnia (sleeplessness): 6 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Cancidas and Lopurin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cancidas and Lopurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cancidas:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lopurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cancidas and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopurin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on caspofungin acetate and allopurinol (the active ingredients of Cancidas and Lopurin, respectively), and Cancidas and Lopurin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: